Management of the indolent non-Hodgkin's lymphomas

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue.

Clinical lymphoma, myeloma & leukemia·2021

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Leukemia & lymphoma·2016

Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

Annals of oncology : official journal of the European Society for Medical Oncology·2009

Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Seminars in oncology·2026

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Seminars in oncology·2026

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

Seminars in oncology·2026

From spatial maps to treatment decisions: a roadmap for integrating explainable AI with multi-omics to guide precision immunotherapy.

Biotechnology notes (Amsterdam, Netherlands)·2026

A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions.

NPJ precision oncology·2026

A deceptive fungating breast mass: giant fibroadenoma with multiple epidermal inclusion cysts mimicking malignancy.

Future science OA·2026

Compartment-specific inflammation in tuberculous lymphadenitis: a case-control study.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026

Unveiling the Conundrum: Genital Tuberculosis with Omental Tubercles and Uterine Leiomyoma Masquerading as Malignancy.

International journal of applied & basic medical research·2026

Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.

Cancer pathogenesis and therapy·2026

Related Experiment Videos

Management of the indolent non-Hodgkin's lymphomas

Related Concept Videos

Noninvasive Monitoring of Mantle Cell Lymphoma by Immunoglobulin Gene Next-Generation Sequencing in a Phase 2 Study of Sequential Chemoradioimmunotherapy Followed by Autologous Stem-Cell Rescue.

Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.

Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.

Stanford V program for locally extensive and advanced Hodgkin lymphoma: the Memorial Sloan-Kettering Cancer Center experience.

Infectious disease associations in advanced stage, indolent lymphoma (follicular and nonfollicular): developing a lymphoma prevention strategy.

Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Uncovering an uncommon diagnosis: Encapsulated papillary carcinoma of the male breast in a Jordanian patient-A case report.

Silver nanoparticles in tumor microenvironment modulation: Mechanistic insights, preclinical evidence, and translational challenges.

From spatial maps to treatment decisions: a roadmap for integrating explainable AI with multi-omics to guide precision immunotherapy.

A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions.

A deceptive fungating breast mass: giant fibroadenoma with multiple epidermal inclusion cysts mimicking malignancy.

Compartment-specific inflammation in tuberculous lymphadenitis: a case-control study.

Unveiling the Conundrum: Genital Tuberculosis with Omental Tubercles and Uterine Leiomyoma Masquerading as Malignancy.

Integrin α3 (ITGA3) expression across breast cancer subtypes: Prognosis and therapeutic relevance.

Related Experiment Videos

Management of the indolent non-Hodgkin's lymphomas

Related Concept Videos

Related Articles